INTRODUCTION
The gp120 envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1) is conformationally flexible and undergoes substantial structural rearrangements during HIV-1 entry into cells (Guttman et al., 2012; Myszka et al., 2000; Wyatt et al., 1998) . gp120 consists of several autonomously folded domains, namely, the outer domain, the inner domain, the bridging sheet, and the V1/V2 region, and these domains may adopt different relative spatial arrangements in response to ligand binding or oligomeric interactions within the functional viral spike (Chen et al., 2005 (Chen et al., , 2009 McLellan et al., 2011; Pancera et al., 2010; Zhou et al., 2007) . In the conformation of gp120 induced by engagement of the CD4 receptor, an interfacial cavity forms at the nexus of the inner domain, the outer domain, the bridging sheet, and the CD4 receptor . This interfacial cavity, called the ''Phe43 cavity'', is capped on one end by the phenyl ring of residue 43 CD4 and bordered by conserved gp120 residues, and its volume is $150 Å 3 (for clarity, residue numbers are subscript labeled with the macromolecule of which they are a part). Natural amino acids cannot fully access the Phe43 cavity, which extends $8 Å beyond the phenyl ring of residue 43 CD4 . Synthetic chemistry offers the opportunity to interact fully with this cavity via nonnatural, cavity-filling ligands (Curreli et al., 2012; Huang et al., 2005; Lalonde et al., 2011 Lalonde et al., , 2012 Stricher et al., 2008) . One such synthetic system was developed by transplanting critical elements of the gp120-interactive region of CD4 to a structurally compatible scyllatoxin scaffold (Vita et al., 1999) . Structure-guided optimizations of the miniprotein backbone (Martin et al., 2003; Stricher et al., 2008) , as well as the side chain of residue 23 miniprotein , which is located in a position analogous to that of residue 43 CD4 (Huang et al., 2005) , resulted in M48 and M47, both with nanomolar affinity for gp120 (Stricher et al., 2008) . M48 contains a Phe at position 23 M48 (Table 1) , whereas M47 inserts a biphenylalanine $5 Å into the Phe43 cavity. The structure of gp120 bound to M48 (Stricher et al., 2008) closely resembled the structure of gp120 bound to CD4, both in overall conformation and in the region near the Phe43 cavity. In the M47-bound gp120 structure, insertion of a rigid biphenyl appeared to distort the gp120 conformation in the region surrounding the insertion (Stricher et al., 2008) . This observation spurred the design of CD4-mimetic miniprotein variants with flexible inserts that extend into the Phe43 cavity (Van Herrewege et al., 2008) .
One of these variants, M48U1, contained a cyclohexylmethoxy phenylalanine at position 23 M48U1 and displayed remarkably potent neutralization of three HIV-1 isolates (Van Herrewege et al., 2008) , and a recent study demonstrated its efficacy as a microbicide (Dereuddre-Bosquet et al., 2012) . To determine the structural basis for the potent antiviral activity of M48U1, we determined its crystal structure in complex with HIV-1 gp120. For comparison, we also determined the structure of M48U7, which contained a 5-hydroxypentylmethoxy phenylalanine at residue 23 M48U7 . Structural, biochemical, and virological analyses of M48U1 and M48U7, as well as those of the previously reported miniproteins M48 and M47, helped to elucidate the structural basis for potent neutralization at the Phe43 cavity of gp120.
RESULTS

Surface Plasmon Resonance Analysis of M48U1 and M48U7
To place the neutralization properties of M48U1 into a biochemical context, we used surface plasmon resonance to determine the binding affinity of M48U1 for YU2 gp120 ( Figure 1A ; Table 1;  Table S1 available online). With gp120 immoblized on a CM5 chip, we observed an extraordinary affinity of 0.0154 ± 0.0008 nM ( Figure 1A ; Table 1) , and association and dissociation rates of 2.53 3 10 6 M À1 s À1 and 3.9 3 10 À5 s À1 , respectively (Figure 1A; Table S1 ). To verify affinity, we reversed the experimental format by coupling M48U1 to a CM5 chip via Lys11 M48U1 . A binding affinity of 0.014 ± 0.005 nM was observed ( Figure S1 ), comparable to the affinity obtained with gp120 immobilized. gp120 affinity for the closely related CD4-mimetic miniprotein, M48U7, was 0.18 ± 0.03 nM ( Figure 1B) , with an association rate of 2.42 3 10 6 M À1 s À1 and an off rate of 4.46 3 10 À4 s À1 .
For comparison, sCD4 and the CD4-mimetic miniproteins, M48 and M47, have gp120 binding affinities of 7.7 nM, 4.0 nM, and 2.1 nM, respectively (Stricher et al., 2008) . Thus, M48U1 displayed more than 100-fold tighter binding to YU2 gp120 compared to sCD4 and previously characterized CD4-mimetic miniproteins, and 10-fold tighter binding compared to M48U7 (Table 1; Table S1 ). The remarkable affinity of M48U1 for gp120 was contributed by both its higher rate of association with gp120 and its slower dissociation rate. Although M48U1 and M48U7 both showed tighter affinities to gp120 compared to sCD4, M48, and M47, the discriminating factor between these two miniproteins was their off rates, with M48U1 dissociating from gp120 about 10 times slower than did M48U7.
Crystal Structures of gp120 Bound to CD4-Mimetic Miniproteins
To gain structural information on the gp120 interactions of M48U1 and M48U7, we crystallized the miniproteins in complex with a truncated version of YU2 gp120 (YU2core e ) . Complexes crystallized as plates in two related space groups, P2 1 2 1 2 1 and C222 1 (Table 2) . For M48U1, the C222 1 crystal form contained one complex in the asymmetric unit and diffracted to 1.49 Å , and the P2 1 2 1 2 1 crystal form contained two molecules in the asymmetric unit and diffracted to 1.8 Å . M48U7 crystallized in the C222 1 crystal form and diffracted to 2.1 Å . Unless otherwise noted, the C222 1 crystal forms of each complex were used for structural comparisons. Structures were solved by molecular replacement using gp120-M48 coordinates from Protein Data Bank [PDB] ID 2I60 (Stricher et al., 2008 ) as a search model. Unoccupied density was visible in the Phe43 cavity, into which either U1 or U7 inserts were built. Multiple cycles of simulated annealing, TLS, ADP, positional refinement, and automated water picking were employed, and these were alternated with manual model building to obtain final R free /R work values of 22.3%/18.2% and 18.5%/16.5% for gp120-M48U1 structures in space groups P2 1 2 1 2 1 and C222 1 , respectively, and 21.9%/18.0%, for the gp120-M48U7 structure (Table 2) .
M48U1 and M48U7 bound at the gp120 CD4-binding site, at the intersection of three gp120 domains (Figures 2A and 2B) . The observed gp120 conformations in the M48U1 and M48U7 bound states were similar to each other, with an overall Ca rmsd of 0.31 Å , and within the range of variation observed for CD4 and other CD4-mimetic miniproteins (Huang et al., 2005; Stricher et al., 2008) .
CD4-Mimetic Features in M48U1 and M48U7 Cocrystal Structures
As a first step toward understanding the structure-function relationship of the CD4-mimetic miniproteins, we compared the structural mimicry of their gp120 recognition with that of CD4. Specifically, we compared gp120-M48U1 and gp120-M48U7 structures to CD4-bound gp120 structures, as well as to gp120 bound to CD4-binding-site antibodies like VRC01 that bind the CD4-bound conformation of gp120 and others such as b12, b13, and F105, which have been shown to induce non-CD4-bound conformations of gp120 ( Figure S2) . Overall, the conformation of gp120 core bound to M48U1 or M48U7 appeared similar to the CD4-bound conformation of core gp120 (Figures 2A and 2B) , with main-chain rmsds of 0.73 and 0.82, respectively, in relation to CD4-bound gp120 (PDB ID 1RZK), and differed from other structurally characterized non-CD4-bound gp120 conformations (b12-bound, b13-bound, F105-bound, and unliganded SIV conformation) (Chen et al., 2005 (Chen et al., , 2009 Zhou et al., 2007) . The exposed edge of the C-terminal b strand of M48U1 and M48U7 forms a hydrogen bond with the b15-strand of gp120 in an antiparallel manner similar to that observed for the CDR2-like loop of CD4 ( Figures 2C and 2E ). Both miniproteins use Arg9 miniprotein to engage the highly conserved Asp368 gp120 in a salt bridge interaction reminiscent of the interaction CD4 makes via its Arg59 CD4 . A critical interaction at the gp120-CD4 interface is made by the Phe43 CD4 side chain, which caps the mouth of the Phe43 cavity. This phenyl interaction is preserved with each of the CD4-mimetic miniproteins (Table 1 ; Figures 2C-2F ) (Huang et al., 2005; Stricher et al., 2008 ) via residue 23 miniprotein , which is a Phe in M48 and a Phe-derivative in the other miniproteins. Thus, like the CD4-mimetic miniproteins previously described (Huang et al., 2005; Stricher et al., 2008) , M48U1 and M48U7 mimic critical structural elements of CD4 recognition of gp120, including an intermolecular antiparallel b-strand interaction with the b15-strand of gp120, a salt bridge with Asp368 gp120, and insertion of a phenyl cap at the mouth of the gp120 Phe43 cavity.
Interactions of M48U1 and M48U7 within the Phe43 Pocket The only chemical difference between the miniproteins was in their Phe43-cavity inserts (Table 1) . Analysis of the miniprotein interface with gp120 showed that interactions outside the Phe43 cavity were overall similar in the different miniprotein complexes (Table S2) , with variation between the different miniproteins equivalent to the variation between different complexes of the same miniprotein. This led us to reason that the remarkable gp120-binding and neutralization properties of M48U1, and its differences from the other miniproteins, were likely related to their Phe43-cavity interactions. We therefore focused our attention on the Phe43 cavity and sought to understand the details of its interaction with residue 23 miniprotein , which penetrates the cavity. With a phenyl capping the mouth of the Phe43 cavity, the cyclohexylmethoxy (U1) in M48U1 and the 5-hydroxypentylmethoxy (U7) in M48U7 extended 6.5 Å and 6.2 Å , respectively, into the Phe43 cavity ( Figures 2D and 2F ). The Phe43 cavity is predominantly nonpolar, with islands of polarity contributed by (1) polar atoms from residues lining the cavity walls (mainchain O atoms of Ser375 gp120 , Val255 gp120 , Phe376 gp120 , and Asn425 gp120 ; main-chain N atoms of Ser256 gp120 , Phe376 gp120 , and Asn377 gp120 ; and side-chain O atoms of Ser375 gp120 and Tyr384 gp120 ); (2) a conserved solvent channel $6.2 Å from the cavity mouth; and (3) an opening at the interior apex of the cavity capped by a water molecule (W1) (Figure 3 ).
U1 is predominantly nonpolar and makes hydrophobic interactions with residues lining the Phe43-cavity walls. The only polar region on U1 is its ether oxygen, which is oriented toward the gp120 solvent channel. The observed distance between the ether oxygen and the nearest water of the solvent channel is 3.6 Å in all three asymmetric units, slightly beyond standard hydrogen-bonding distance. The cyclohexyl group fills the inner recess of the Phe43 cavity, interacting with Phe382 gp120 , Trp112 gp120 , and Val255 gp120 , which form a hydrophobic cluster at the cavity ceiling ( Figures 3A-3D ).
U7 is an alkyl alcohol with greater conformational freedom compared to U1. U7 accommodates its terminal hydroxyl group in a predominantly hydrophobic pocket by directing the hydroxyl away from hydrophobic regions and orienting it toward polar regions of the Phe43 cavity. Whereas the alkyl chain interacts with the hydrophobic walls of the Phe43 cavity, the hydroxyl moiety appears in two distinct conformations, one hydrogen bonding with the Ser375 gp120 hydroxyl group and the other with the gp120 solvent channel ( Figure 3B ).
M48U1 and M48U7 are two examples of how Phe43-cavitypenetrating ligands can utilize different chemistries and conformations to interact with this cavity. In summary, the U1 moiety in M48U1 makes 11 hydrophobic interactions with gp120, and the U7 moiety in M48U7 makes eight hydrophobic interactions and one hydrogen-bond interaction in each of its two conformations, showing an overall qualitative similarity between the number of contacts that the two inserts make with the Phe43 cavity.
Residual Flexibility of U1 and U7 in Their Bound States While X-ray crystal structures principally offer static snapshots of macromolecular states, information on relative flexibility, disorder, and movement can sometimes be gleaned from features presented by electron density maps. The residue 23 M48U7 phenyl ring shows a well-defined electron density ( Figure 2F ), whereas its alkyl chain shows two distinct conformations, with the terminal hydroxyl in each conformation oriented toward a polar region in the Phe43 cavity.
The electron density of gp120-bound U1 also revealed residual flexibility ( Figure 2D ). The U1-cyclohexane ring showed asymmetric electron density, with some regions showing A very slow dissociation rate contributes to the extraordinary affinity of M48U1 for gp120. M48U7 binds with a similar on-rate but dissociates from gp120 about 10-times faster than M48U1. Surface-plasmon-resonance profiles of the binding of M48U1 (A) and M48U7 (B) to full-length HIV-1 gp120 from the clade B YU2 strain. The black lines indicate independent injections of the CD4-mimetic miniproteins with concentrations sampled at 2-fold dilution. Concentrations from 3 nM to 0.006 nM and from 8 nM to 0.06 nM were sampled for M48U1 and M48U7, respectively. Each concentration was sampled in duplicate. The red lines show the global fit of the data to a Langmuir 1:1 binding model. A surface-plasmon-resonance profile of HIV-1 YU2 gp120 binding to M48U1 immobilized on a CM5 chip is shown in Figure S1 . Binding affinities are listed with their standard errors.
well-defined electron density and other regions showing poorly defined electron density, the latter suggestive of multiple conformations unconstrained by interactions with the Phe43 cavity. The methoxy cyclohexyl moiety in the C222 1 crystal form was more disordered than the complexes in the P2 1 2 1 2 1 crystal form and was modeled as two alternate conformations. For clarity, the predominant conformation found in both molecules in the asymmetric unit of the P2 1 2 1 2 1 crystal form, as well as the C222 1 crystal form, is shown in the figures. In contrast, the U1 phenyl ring shows symmetric and continuous electron density suggestive of a defined structure, constrained by its interactions with gp120. This is similar to the well-defined electron densities observed for Phe43 CD4 in CD4-bound gp120 structures, for Phe23 M48 in the M48-bound gp120 structure, and for the less buried phenyl ring in Bip23 in the M47-bound gp120 structure Stricher et al., 2008) .
The residual flexibility of U1 in its bound state may play a role in the remarkable neutralization properties of M48U1 by allowing the insert to adapt to changes in the Phe43 cavity conformation as a result of strain-to-strain variation (Shrivastava and LaLonde, 2011) . A similar beneficial effect of inhibitor flexibility has been shown for HIV-1 proteases, where flexible inhibitors better resist active-site variations and suffer less entropic penalty compared to rigid inhibitors (Vega et al., 2004) .
M48U1 and M48U7 are two examples of ligands utilizing their flexibility to maximize interactions and avoid potential clashes in protein-binding sites. Although U1 and U7 moieties are both flexible, and both retain mobility in their bound states, M48U1 and M48U7 differ substantially in their gp120 binding affinities and HIV-1 neutralization potencies. This suggests that not only is ligand flexibility important, but the precise shape or geometry of the ligand may also contribute to its binding affinity to the Phe43 cavity.
Shape Complementarity and Surface Burial of the CD4-Mimetic Miniproteins at the gp120 Phe43 Cavity To estimate the goodness of fit of each miniprotein insert to the Phe43 cavity, we calculated the shape complementarity (SC) (Lawrence and Colman, 1993) of the insert to the binding pocket, as well as its buried surface area (Krissinel and Henrick, 2007) (Table 3) . SC measures the geometric surface complementarity of interfaces and depends both on the relative shape of the surfaces and the extent to which the interaction brings individual elements of the opposing surfaces into proximity. We calculated SC for Phe43 cavity inserts from CD4 and the CD4-mimetic miniproteins M48, M47, M48U1, and M48U7 (Table 3) . Phe43 CD4 , a natural Phe43-cavity ligand, showed the highest SC statistic, indicating the best shape complementarity. SC of Phe23 M48 
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matched closely with that of Phe43 CD4 , consistent with published reports that show M48 to be a close structural mimic of CD4 (Stricher et al., 2008) . Of the other three CD4-mimetic miniproteins (Table 1) , M48U1 had the highest SC (Table 3) of 0.762, followed by M47, and M48U7 showed the lowest SC of 0.703. These results revealed that nonnatural excursions into the Phe43 cavity resulted in reduced overall shape complementarity compared to the fit of the natural phenyl, and that of these nonnatural excursions, U1 showed the best shape complementarity (Figures 3E and 3F ; Table 3 ). The extent of surface burial is another determinant of intermolecular interaction, with a larger shared interfacial area between two molecules suggesting more interfacial contacts and better binding. We calculated buried surface areas for all the Phe43-cavity inserts (Table 1) . As expected CD4 and M48 showed the least surface burial (Table 3) since they have the smallest Phe43-cavity insert. Phe43 CD4 and Phe23 M48 bind the Phe43-cavity mouth, leaving the rest of the cavity unoccupied. M48U1 and M48U7 showed the highest surface burial, followed by M47.
Shape complementarity and surface burial are two independent parameters, with shape complementarity being a measure of local fit of the two binding partners and surface burial a measure of their total interfacial area. Since both parameters contribute to overall fit, we empirically derived a combined fit parameter by multiplying SC by the buried surface area for each pair of interactions (Table 3) . This combined fit parameter showed that M48U1 had the best overall fit to the Phe43 cavity, followed by M48U7, M47, and M48 in decreasing order of overall fit.
Structural Changes in gp120 Related to Ligand Insertion into the Phe43 Cavity
We next sought to understand Phe43 cavity conformational changes in response to ligand binding. Although overall the conformation of gp120 core e bound to M48U1 or M48U7 resembled the CD4-bound conformation (Figures 2A and 2B; Figure S2) , local conformational changes in the vicinity of the bound ligand may affect ligand fit and influence binding affinity. To understand the effect of ligand insertion on the conformation of the Phe43 cavity, we analyzed gp120 conformational changes in the vicinity of the U1 or U7 insertion.
For precise definition of the cavity, we used the algorithm fpocket (Le Guilloux et al., 2009 ). The highest-scoring pocket was a 505 Å 3 space made up of two intersecting regions-the Phe43 cavity and a conserved gp120 solvent channel (Figures  2 and 3 ; Figure S3 ). This bifurcated cavity is made up of residues from the bridging sheet, the a1 and a3 (commonly known as the CD4 binding loop) helices, and loop B. A conserved solvent channel starts from an opening in the Phe43 cavity, about 6.2 Å from the cavity mouth, and connects the gp120 CD4 binding site to the coreceptor binding site (Figures 3A and 3D ; Figure S3 ). U1 and U7 bind to the Phe43 cavity, extending into the gp120 hydrophobic core, thereby filling a region of topological mismatch in gp120's hydrophobic interior (Figures 2 and 3) . To study local effects of ligand binding, we first calculated Phe43-cavity volume in each of the complexes in the absence of ligand ( Figure S4 ). The calculated volumes were overall similar between the miniprotein complexes. We then analyzed ligand-induced changes in the Phe43 cavity at the residue level by constructing distance-sorted difference distance matrices (Huang et al., 2005) . This structural analysis technique was earlier used to study gp120 conformational changes on binding to M48 and M47 (Huang et al., 2005; Stricher et al., 2008) . Difference distance matrices allow superposition-independent and residuespecific structural comparison, and overall summations are obtained by calculating the rms of matrix elements. See also Figure S2 .
Structure
A distance-sorted double sieve was used to derive the subset of atoms for difference-distance-matrix calculations. First, atoms lining the cavity were selected using the program fpocket. Next, atoms from this subset that were %6Å from M48U1 were selected. Finally, these atoms were sorted by their distance from the 23 M48U1 Ca atom. The Ser375 side-chain hydroxyl and Ile424 CG1 were found at different positions in various CD4-and mimetic-bound structures as a result of stochastic rotameric variation, and were therefore disregarded for the analysis. Figure 4 tabulates the set of atoms used for this analysis. .
(E) Zoomed-in view of the U1 moiety inserting into the Phe43 cavity.
(F) Zoomed-in view of the U7 moiety inserting into the Phe43 cavity. The CD4-binding footprint is colored yellow. In the multilayer transparent surface representation shown in (E) and (F), the outer surface is gp120 and the inner surface is the ligand.
Interactions of M48U1 and M48U7 outside the Phe43 cavity are shown in Table S2 .
We first analyzed differences in the Phe43 cavity between unliganded YU2 core gp120 (PDB ID 3TGQ) and YU2 core gp120 bound to CD4 and 17b, a CD4-induced (CD4i) antibody that stabilizes the CD4-bound conformation (PDB ID 1RZK), by constructing difference distance matrices. We detected CD4-binding-induced movement in the gp120 Phe43 cavity (Figures 4 and 5A) . The largest conformational perturbations were found, as expected, closest to the region of Phe43 CD4 insertion in gp120, with changes progressively decreasing in magnitude at increasing distances from the region of Phe43 CD4 insertion. It is pertinent to note that the net relative change on CD4 binding suggests overall contraction of the Phe43 pocket, especially surrounding the region of Phe43 CD4 insertion. This qualitatively represents a transition from a relaxed state of the gp120 domains to a state constrained by Phe43 CD4 insertion at the mouth of the Phe43 cavity, with the gp120 domains brought closer by their interaction with Phe43 CD4 .
We compared M48U1-bound and M48U7-bound gp120 to unliganded and CD4-bound core gp120 (Figures 4 and 5B-5E ), and found that the Phe43 cavity, when bound to these CD4 mimetics, showed greater resemblance to the Phe43 cavity in unliganded core gp120 (gp120 core e ) than to that in CD4-bound gp120. This finding is consistent with the propensity of the Phe43 cavity to be filled, as inferred from crystal structures that show small molecules from crystallization solutions occupying the Phe43 cavity ( Figure S4 ), and suggests that cavity filling leads to stabilization of the Phe43 cavity. Residue 23 M48U1/M48U7 insertions fill the Phe43 cavity, thereby stabilizing its relaxed or ground state by counteracting the partial ''Phe43-cavity collapse'' induced by CD4 binding. We also observed localized movement in the Phe43 cavity in response to U1 and U7 insertion. These changes were most dominant at the deeper end of the Phe43 cavity, and in the case of U1, involved residues Phe382 gp120 , Trp112 gp120 , and Val255 gp120 which form a hydrophobic/aromatic cluster near the ceiling of the cavity, and Ile424 gp120 ( Figures 3A, 3C , 4, and 5).
We expanded this analysis to CD4-mimetic miniproteins M48 and M47 (Stricher et al., 2008) (Figure 6 ). We found that the M48-bound Phe43 cavity resembled the CD4-bound cavity more than the unliganded core gp120 cavity. Binding to M47 distorted the Phe43 cavity more than any of the other CD4-mimetic shows greater resemblance to the Phe43 cavity in unliganded gp120 than to the Phe43 cavity in gp120 bound to CD4 and CD4-induced monoclonal antibody 17b. Distance-sorted difference distance matrices of gp120 were constructed using coordinates of atoms lining the gp120 Phe 43 cavity selected with fpocket. Atoms within 6 Å of U1 were sorted in increasing order of distance from the Phe43 Ca atom of CD4 and are shown at the far left, along with the corresponding gp120 residue. The columns in this panel, from left to right, denote distances in Å from the Ca of CD4 Phe43, residue names, residue numbers, and atom names. Difference distance matrices composed of these cavity atoms were calculated for unliganded YU2 gp120 and for gp120 complexes with CD4, M48U1, and M48U7. Each i,j matrix element shows the distance between atom i and atom j in the first specified structure minus the distance between the same atoms in the second specified structure. The difference distance matrix was quantified by mean difference distances, and is shown for each comparison. Physical and chemical properties of the gp120 Phe43-cavity properties are summarized in Figure S3 .
miniproteins. These findings are consistent with published studies showing that M48 is the closest mimic of CD4 (Stricher et al., 2008) and that M47-bound gp120 deviates from the CD4-bound structure around the ligand-binding site. We also found that M47-and M48-bound states of the Phe43 cavity are more similar to each other than they are to the Phe43 cavity bound to either M48U1 or M48U7, and that the differences are highest in magnitude at the deeper regions of the Phe43 cavity (R13 Å from the Ca of 23 M48U1 ), where U1 and U7 inserts make additional contacts unexplored by either M48 or M47 (Figure 6 ; Figure S5 ). Taken together, these results show that by inserting flexible moieties into the Phe43 cavity, M48U1 and M48U7 induce a Phe43-cavity conformation in core gp120 that is very close to its ground-state conformation. This state is similar to, but distinct from, the conformation the cavity assumes when core gp120 binds the CD4 receptor. Further, these analyses show that the Phe43 cavity is malleable and can adapt its conformation to fit an incoming ligand. Despite this malleability, the fact that the various CD4-mimetic miniproteins have different affinities suggests that recognition of the ground state appears to be substantially more favorable energetically than recognition of slightly altered conformations.
HIV-1 Neutralization by M48U1 and M48U7
To understand the effect of M48U1 binding to the HIV-1 trimeric spike, we assessed its ability to neutralize HIV-1, and compared it to HIV-1 neutralization by sCD4, M48, M47, and M48U7 (Figure 7 ; Figure S6 ; Table 3; Table S3 ). We tested a panel of 24 pseudoviruses ( Figure 7A ; Table 3 ), selected from different clades, for their susceptibility to be neutralized by either M48U1 or M48U7. M48U1 neutralized 20 of the 24 isolates (83%), with a geometric half-maximal inhibitory concentration (IC 50 ) mean of 0.39 mg/ml. In comparison, M48U7 neutralized only 67% of the 24 isolates tested, with a geometric IC 50 mean of 5.18 mg/ml. M48U1 was also shown to be a better neutralizer than all other currently known CD4-mimetic miniproteins of this class (Van Herrewege et al., 2008) .
For a more comprehensive estimate of its neutralization efficacy, M48U1 was tested in an expanded panel of 180 HIV-1 Figure 5 . Ligand-Induced Motion in the gp120 Phe43 Cavity A cross-section of gp120 is shown as a transparent gray surface. Phe43 cavity atoms are shown as spheres, and the corresponding residues as sticks. Distancesorted difference distance matrices of the gp120 Phe43 cavity bound to the different ligands, shown in Figure 4 , were used to calculate net motion at each cavity atom. The cavity atoms were colored with a yellow-white-magenta gradient, where yellow represents the least motion and magenta represents the highest differences between gp120 bound to CD4 (yellow) and 17b IgG versus unliganded gp120 (A), gp120 bound to M48U1 (red and green) versus unliganded gp120 (B), gp120 bound to M48U1 versus gp120 bound to CD4 and 17b IgG (C), gp120 bound to M48U7 (red and cyan) versus unliganded gp120 (D), and gp120 bound to M48U7 versus gp120 bound to CD4 and 17b IgG (E). Analysis of the Phe43-cavity volume is shown in Figure S4. isolates representative of circulating Tier 1 and Tier 2 viruses. M48U1 neutralized all isolates tested, except viruses from clade A/E, with 90% overall breadth and geometric IC 50 mean of 0.13 mg/ml (Figure 7 ; Table 3 ). In comparison, CD4 neutralizes a similar HIV-1 panel with 79% breadth (Table 3; Figure S6 ) and the CD4-binding site broadly neutralizing antibody VRC01 neutralizes HIV-1 with 91% breadth .
M48U1 neutralized all viruses tested other than isolates belonging to clade A/E, a clade prevalent in Central Africa and Southeast Asia. In addition, none of the clade A/E viruses tested in this study were neutralized by M48U7. All clade A/E viruses tested had His at position 375, whereas all of the other HIV-1 clades tested contain the canonical Ser at position 375. Clade A/E CA10.3, harboring a Ser375, was shown to be efficiently neutralized by M48U1 (Van Herrewege et al., 2008) . As inferred from the structure of HIV-1 clade A/E 93Th057 gp120 (PDB ID 3TGT) , His375 partially fills the Phe43 pocket, thereby hindering access by the U1 and U7 moieties, allowing the virus to resist a cavity-penetrating ligand yet remaining entry competent by retaining binding to CD4, which only accesses the mouth of the Phe43 pocket. In addition, S375R/N mutations have been implicated in viral resistance to M48U1 (Grupping Distance-sorted difference distance matrices of gp120 were constructed using the same set of atoms as in Figure 4 . Difference distance matrices were calculated to compare Phe43-cavity conformations of gp120 bound to CD4-mimetic miniproteins M48, M47, M48U1, and M48U7, relative to each other. Each i,j matrix element shows the distance between atom i and atom j in the first specified structure minus the distance between the same atoms in the second specified structure. The difference distance matrix was quantified by the overall mean of the difference distances, and is shown for each comparison. Structural changes in the Phe43-cavity conformation upon binding to different cavity-filling ligands are shown in Figure S5 . et al., 2012) , consistent with the substrate-binding-envelope hypothesis for drug design from Schiffer and colleagues (Prabu-Jeyabalan et al., 2002) , which postulates that inhibitors that venture out of the envelope defined by natural susbtrates are more susceptible to developing viral resistance under selective pressure of the inhibitor (King et al., 2004) . Viral resistance to ligands that access the inner recesses of the Phe43 pocket when a bulky amino acid is placed at position 375 of gp120 has been reported earlier for the nitrobenzoxadiazole class of compounds .
DISCUSSION
In this study, we have compared the gp120 Phe43 cavity conformation in unliganded and CD4-bound core gp120 with its conformation when bound to two flexible ligands of differing chemistry that insert into this cavity. Although the ligands varied in their respective ability to neutralize HIV-1, the conformation of the Phe43 cavity in both cases resembled the unliganded conformation of core gp120 more than the CD4-bound conformation. Analysis of the affinities of the various CD4-mimetic miniproteins, as well as of their recognized or induced Phe43-cavity conformations, suggests that deviations of the Phe43 cavity from the presumed ground state require substantial energy. Only by optimizing a combination of chemistry, Phe43-cavity filling, and complementary shape can the potential of the Phe43 cavity be realized-in this case by near-panneutralization of HIV-1 and by a gp120 affinity for M48U1 of 0.015 nM.
CD4 makes a functionally critical interaction with the HIV-1 envelope, yet soluble CD4 only neutralizes HIV-1 moderately. This is believed to be related to ''conformational masking'', the requirement of conformational change of the viral spike to permit CD4 binding, a requirement that trades CD4 affinity in the monomeric gp120 context for induction of the CD4-bound state in the viral spike (Kwong et al., 2002) . Two prior mechanisms have been identified for CD4-binding-site ligands that nevertheless achieve broad and potent HIV-1 neutralization: (1) Aviditymultivalent versions of CD4 that are able to engage more than one gp120 on the viral spike potently neutralize diverse strains of HIV-1 (Arthos et al., 2002; Trkola et al., 1995) , presumably by spreading the energy required to change spike conformation over several binding sites; (2) Avoiding conformation changeantibody VRC01 is able to bind without inducing conformational changes in the viral spike, allowing this antibody to neutralize >90% of circulating HIV-1 isolates . Here, we focus on a third mechanism: optimization of the interaction of the CD4-binding-site ligand with the interfacial Phe43 cavity. In particular, we show that a CD4-mimetic ligand that gains affinity by optimizing contacts in the Phe43 cavity can effect broad and potent HIV-1 neutralization. This observation that high-affinity binding can overcome the restrictions imposed by conformational masking may have important implications for neutralization at the CD4-binding site of the HIV-1 envelope. It may be possible to combine this third mechanism with the two identified previously. A multimeric M48U1, for example, might have higher potency than monomeric M48U1. Chemical modifications of a Phe43Cys variant of CD4 have also been explored (Xie et al., 2007) . Also, recent studies have shown that engaging the gp120 Phe43 cavity can lead to enhanced neutralization by CD4-binding-site antibodies (Diskin et al., 2011) . Thus, although engagement of the Phe43 cavity may lead to a conformational change of the HIV-1 envelope, our results demonstrate that optimizing ligand fit in the Phe43 cavity can nonetheless lead to potent, near-pan-neutralization of HIV-1. Induction of conformational change further allows the possibility of combining these potent inhibitors with entry inhibitors that target the CD4i site of coreceptor binding on gp120 (Acharya et al., 2011; Lagenaur et al., 2010) or with inhibitors that target transient viral-envelope intermediates farther downstream in the HIV-1 entry pathway (Chen et al., 2002; Reeves et al., 2005) .
In summary, our studies provide a structural explanation for the broad and potent neutralization by the CD4-mimetic miniprotein M48U1. They show that achieving optimal fit to the Phe43 cavity can be an effective means of enhancing the neutralization capability of a CD4-binding-site ligand. These results provide frameworks, both mechanistic and structural, for optimizing the interaction of CD4-binding-site ligands with the Phe43 cavity, a conserved site of HIV-1 vulnerability and a proven target for HIV-1 neutralization.
EXPERIMENTAL PROCEDURES
Synthesis of CD4-Mimetic Miniproteins, gp120 Expression, and Purification M48U1, M48U7, M48, and M47 were synthesized by solid-phase methods, as described elsewhere (Martin et al., 2003) . The concentrations of the peptides in solution were determined by hydrochloric acid hydrolysis followed by amino acid analysis. HIV-1 clade B YU2 gp120 core e was expressed, purified, and deglycosylated as previously described (Kwon et al., Table S3 . Neutralization dendrograms of sCD4, M48, and M47 are shown in Figure S6 . The molecular weights of M48U1 and M48U7 are 3,048 Da and 3,038 Da, respectively.
